NARNI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 15.291
EU - Europa 6.752
AS - Asia 5.183
SA - Sud America 785
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 28.119
Nazione #
US - Stati Uniti d'America 15.142
GB - Regno Unito 2.706
CN - Cina 1.746
SG - Singapore 1.462
SE - Svezia 898
IT - Italia 882
HK - Hong Kong 815
DE - Germania 622
BR - Brasile 609
UA - Ucraina 363
RU - Federazione Russa 329
VN - Vietnam 324
TR - Turchia 294
FI - Finlandia 271
FR - Francia 182
BG - Bulgaria 135
KR - Corea 114
IN - India 112
CA - Canada 77
AR - Argentina 66
ID - Indonesia 63
ES - Italia 59
JP - Giappone 50
IE - Irlanda 43
BD - Bangladesh 40
BE - Belgio 40
PL - Polonia 38
MX - Messico 36
CZ - Repubblica Ceca 35
LT - Lituania 30
NL - Olanda 30
ZA - Sudafrica 30
EC - Ecuador 26
MY - Malesia 23
VE - Venezuela 23
AT - Austria 21
IQ - Iraq 19
AE - Emirati Arabi Uniti 17
CO - Colombia 17
IR - Iran 15
UZ - Uzbekistan 13
BZ - Belize 12
CL - Cile 12
EU - Europa 12
CH - Svizzera 11
MA - Marocco 11
RO - Romania 11
EG - Egitto 10
IL - Israele 10
PY - Paraguay 10
AU - Australia 9
PE - Perù 9
PK - Pakistan 9
PT - Portogallo 8
UY - Uruguay 8
AZ - Azerbaigian 7
JO - Giordania 7
KE - Kenya 7
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
KG - Kirghizistan 5
PA - Panama 5
AL - Albania 4
DK - Danimarca 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
MK - Macedonia 4
NP - Nepal 4
TW - Taiwan 4
BO - Bolivia 3
CR - Costa Rica 3
CY - Cipro 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
AM - Armenia 2
BY - Bielorussia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GA - Gabon 2
LV - Lettonia 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A1 - Anonimo 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CU - Cuba 1
DM - Dominica 1
Totale 28.097
Città #
Southend 2.098
Fairfield 1.582
Santa Clara 1.320
Ashburn 1.290
Woodbridge 993
Singapore 898
Chandler 841
Houston 833
Hong Kong 809
Ann Arbor 738
Jacksonville 711
Seattle 588
Dearborn 575
Hefei 564
Wilmington 556
Nyköping 552
Cambridge 505
New York 344
London 324
Beijing 267
Chicago 252
Modena 252
Los Angeles 245
San Diego 151
Princeton 142
Izmir 134
Sofia 133
Munich 131
Eugene 128
Ho Chi Minh City 123
Helsinki 113
Seoul 111
Buffalo 88
Salt Lake City 86
Council Bluffs 81
Fremont 80
Bremen 71
Moscow 69
Shanghai 64
The Dalles 64
Hanoi 57
Dallas 56
Columbus 53
San Jose 53
Milan 51
Boardman 50
São Paulo 50
Des Moines 49
Jakarta 44
Bologna 42
Dublin 42
Brussels 40
Elk Grove Village 39
Redwood City 39
Tampa 38
Tokyo 38
Turku 38
Frankfurt am Main 33
Phoenix 28
Warsaw 28
Washington 27
Atlanta 25
Brooklyn 25
San Francisco 25
Dong Ket 24
Las Vegas 24
Rome 24
Toronto 24
Orem 23
Lancaster 22
Montreal 22
Sterling 22
Chennai 21
Miami 21
Nanjing 21
Brno 20
Denver 20
Guangzhou 20
Rio de Janeiro 19
Stockholm 19
Haiphong 18
Johannesburg 18
Kunming 18
Norwalk 18
Kilburn 17
Mountain View 17
Poplar 17
Albuquerque 15
Verona 15
Indiana 14
Leawood 14
Wuhan 14
Hounslow 13
Nuremberg 13
Quito 13
Belize City 12
Biên Hòa 12
Boston 12
Changsha 12
Da Nang 11
Totale 20.515
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 529
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group 372
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 364
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 342
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 339
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 334
"Biologia molecolare delle leucemie e dei linfomi: Biologia molecolare della cellula, citogenetica e genetica molecolare 332
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 326
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 323
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 320
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 320
Acute appendicitis in adult neutropenic patients with hematologic malignancies 310
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 309
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 307
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. I. The practical management of patients with arrhythmias]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 1: Management pratico nei pazienti portatori di turbe del ritmo. 296
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 296
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 296
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study 294
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 289
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 287
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 286
Mucorales-specific T cells in patients with hematologic malignancies 285
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen 285
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 283
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 279
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 279
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 278
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 278
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 277
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 271
Altered expression of G1 specific genes in human malignant myeloid cells. 267
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 266
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 265
Reassociation kinetics of the DNA of human acute leukemia cells. 264
T cell receptor genes expression in B cell leukaemias. 263
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study 263
Bcl-2 gene expression in hematopoietic cell differentiation. 261
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 260
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 260
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 257
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 257
Accumulation of giant heterogeneous RNA molecules in acute myeloid leukemia blast cells. 254
KAPPA-LIGHT CHAIN GENE REARRANGEMENT IN A T-CELL LYMPHOMA 251
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 250
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 250
[Treatment of the patient with a coagulation defect in oral and maxillofacial surgery. III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota III: Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria di tipo emofilico. 246
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 245
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study 244
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 241
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: Long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 240
Leucemia linfatica cronica 239
[Management of patients with coagulation defect in oral and maxillofacial surgery. I. Management of patients with drug-induced hypocoagulation]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Il management dei pazienti in stato ipocoagulativo farmacoindotto. 239
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 237
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 234
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 233
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 231
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 228
Human Herpes virus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction 228
In vitrocleavage of 45S pre-ribosomal RNA and of giant heterogeneous RNA extracted from human leukemic cells. 227
Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. 225
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 224
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 221
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 220
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 217
Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage.. 215
Treatment of refractory chronic GVHD with Rituximab: a GITMO study 214
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 214
Allogeneic transplantation for multiple myeloma 213
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: Results from the EBMT NMAM2000 prospective trial 212
The primary product of DNA transcription in the blast cell of acute leukemia. Its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia 210
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome 209
ATYPICAL PATTERN OF LIGHT CHAIN GENE REARRANGEMENT IN HAIRY-CELL LEUKEMIA 208
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 207
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 204
Immunological assay of double-helical segments in RNA fractions of different molecular size extracted from acute myeloid leukemia blast cells. 203
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 201
Bortezomib-thalidomide-dexamethasone is superior to thalidomide- dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 200
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 199
[Management of patients with coagulation disorder in oral and maxillofacial surgery. II. Management of patients with hypocoagulation caused by primary thrombocytopathy]. Il trattamento del paziente con difetto di coagulazione in chirurgia orale e maxillo-facciale. Nota II. Il management dei pazienti in stato ipocoagulativo a causa di una patologia primaria trombocitopatica. 199
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 199
Segni sintomi e sindromi: leucocitosi, linfocitosi e linfopenie, linfoadenomegalie, splenomegalie e ipersplenismo. 195
[The treatment of the cardiac patient in dentistry and oromaxillofacial surgery. II. The practical management of patients with hemodynamic pathologies]. Il trattamento del paziente cardiopatico in odontoiatria ed in chirurgia oro-maxillo-facciale. Nota 2: Management pratico nei portatori di patologie emodinamiche. 194
Establishment and characterization of a human IgA-kappa-secreting plasma cell line (MT3). 190
[Management of facial pain resulting from cancer in oral and maxillofacial surgery]. Il trattamento del dolore facciale di natura oncologica in chirurgia oro-maxillo-facciale. 188
Immunological evidence for the presence of double-stranded RNA regions in intact nuclei of normal human lymphocytes 186
Immunoglobulin and T cell receptor beta chain gene rearrangements as lineage markers in human leukemias: a study of 78 cases. HAEMATOLOGICA 72, 391 397, 1987 183
Philadelphia positive chronic myeloid leukemia with 22 breakpoint outside the "beakpoint cluster region" (bcr). 183
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 182
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 180
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: Results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 176
The effect of cytosine-arabinoside treatment on the overexpression of c-myc protooncogene in a case of prolymphocytic leukemia. 174
Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation 174
Molecular study of the Philadelphia translocation in chronic myelogenous leukemia in different stages of the disease. 172
Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia 171
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! 171
HLA class II antigen associated invariant chain gene expression in malignant lymphoma. 168
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 167
Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and sézary syndrome: A European society for blood and marrow transplantation lymphoma working party extended analysis 167
Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. 163
Self complementary sequences in the heterogeneous nuclear RNA of leukemic cells of the HL 60 promyelocytic cell line. 162
Totale 24.546
Categoria #
all - tutte 109.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.611 0 0 0 0 0 182 227 365 139 382 171 145
2021/20222.559 83 320 253 171 56 117 140 153 262 175 534 295
2022/20232.541 346 319 212 243 338 325 65 216 279 25 97 76
2023/20241.773 53 81 102 135 324 302 188 242 27 31 94 194
2024/20254.885 161 53 108 315 950 718 453 247 498 188 468 726
2025/20265.124 673 412 842 1.130 1.571 496 0 0 0 0 0 0
Totale 28.404